Transthyretin, GDF15, FGF21, and alanine:serine ratio showed dependence on the cystatin C–based and creatinine-based eGFR (data not shown) and thus their potential utility in clinical trials may not extend to patients with, or at high risk of, advanced CKD. Here, FGF21 is linked to chronic kidney disease.